World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
26995
World Ranking
1083
National Ranking
583

Medicine

D-Index
91
Citations
27294
World Ranking
11849
National Ranking
6077

Richard J. O'Reilly publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard J. O'Reilly sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 467 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard J. O'Reilly D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard J. O'Reilly sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard J. O'Reilly is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research spans several interconnected fields within medicine, immunology, and hematology, focusing on areas critical to transplantation and immune system disorders.

The scientist's principal fields of study include Medicine and Immunology and Microbiology. Their work prominently addresses several subfields such as Hematology, Immunology, Oncology, Genetics, and Epidemiology. Within these domains, the main topics Richard J. O'Reilly explores are:

  • Hematopoietic Stem Cell Transplantation
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research
  • Cytomegalovirus and herpesvirus research
  • Virus-based gene therapy research
  • Acute Lymphoblastic Leukemia research
  • Immune Cell Function and Interaction

Their recent scholarly output includes contributions to several high-impact journals. Notable recent papers are:

  • "Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors" (2021, Nature Cancer)
  • "The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions" (2022, Journal of Allergy and Clinical Immunology)
  • "Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium" (2023, The Lancet)
  • "CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation" (2020, Blood)
  • "Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial" (2024, The Lancet Oncology)

Frequent publication venues for Richard J. O'Reilly's work include:

  • Transplantation and Cellular Therapy
  • Biology of Blood and Marrow Transplantation
  • Blood Advances
  • Blood
  • Journal of Allergy and Clinical Immunology

Collaboration is a significant aspect of their research career, with common co-authors being:

  • Susan E. Prockop
  • Jaap Jan Boelens
  • Andromachi Scaradavou
  • Nancy A. Kernan
  • Kevin J. Curran

Best Publications

  • Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

    Esperanza B. Papadopoulos;Marc Ladanyi;David Emanuel;Stephen Mackinnon

  • Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

    David Lyden;Alison Z. Young;David Zagzag;Wei Yan

  • Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley

  • Cytomegalovirus Pneumonia after Bone Marrow Transplantation Successfully Treated with the Combination of Ganciclovir and High-Dose Intravenous Immune Globulin

    David Emanuel;Isabel Cunningham;Kethy Jules-Elysee;Joel A. Brochstein

  • Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital Agranulocytosis

    Mary Ann Bonilla;Alfred P. Gillio;Mary Ruggeiro;Nancy A. Kernan

  • Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.

    K. Welte;M. A. Bonilla;A. P. Gillio;T. C. Boone

  • Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

    Nancy A. Kernan;Nancy H. Collins;Lisa Juliano;Teresa Cartagena

  • Bone Marrow–Allograft Rejection by T Lymphocytes Recognizing a Single Amino Acid Difference in HLA-B44

    Katharina Fleischhauer;Nancy A. Kernan;Richard J. O'Reilly;Bo Dupont

  • Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

    Ekaterina Doubrovina;Banu Oflaz-Sozmen;Susan E. Prockop;Nancy A. Kernan

  • Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

    Ekaterina S. Doubrovina;Mikhail M. Doubrovin;Elena Vider;Richard B. Sisson

  • Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts

    Carolyn A. Keever;Trudy N. Small;Neal Flomenberg;Glenn Heller

  • Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience

    William T. Shearer;Elizabeth Dunn;Luigi D. Notarangelo;Christopher C. Dvorak

  • A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

    Susan P. Perrine;Olivier Hermine;Trudy Small;Felipe Suarez

  • Identification by HLA Typing of Intrauterine-Derived Maternal T Cells in Four Patients with Severe Combined Immunodeficiency

    Marilyn S. Pollack;Dahlia Kirkpatrick;Neena Kapoor;Bo Dupont

  • Allogeneic Bone Marrow Transplantation after Hyperfractionated Total-Body Irradiation and Cyclophosphamide in Children with Acute Leukemia

    Joel A. Brochstein;Nancy A. Kernan;Susan Groshen;Constance Cirrincione

  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

    Kevin J Curran;Kevin J Curran;Steven P Margossian;Steven P Margossian;Nancy A Kernan;Nancy A Kernan;Lewis B Silverman;Lewis B Silverman

  • The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation

    Kenneth G. Lucas;Trudy N. Small;Glenn Heller;Bo Dupont

  • Transfusion-Associated Acute Chagas Disease Acquired in the United States

    Irene H. Grant;Jonathan W.M. Gold;Murray Wittner;Herbert B. Tanowitz

  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

    Jennifer Heimall;Brent R. Logan;Morton J. Cowan;Luigi D. Notarangelo

  • Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.

    Guenther Koehne;Mikhail Doubrovin;Ekaterina Doubrovina;Pat Zanzonico

  • TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

    Sandra Kesh;Nana Yaa Mensah;Paolo Peterlongo;Dana Jaffe

Frequent Co-Authors

Nancy A. Kernan
Nancy A. Kernan Memorial Sloan Kettering Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Miguel-Angel Perales
Miguel-Angel Perales Memorial Sloan Kettering Cancer Center
Marcel R.M. van den Brink
Marcel R.M. van den Brink Memorial Sloan Kettering Cancer Center
Glenn Heller
Glenn Heller Memorial Sloan Kettering Cancer Center
Katharine C. Hsu
Katharine C. Hsu Memorial Sloan Kettering Cancer Center
Michel Sadelain
Michel Sadelain Columbia University
Bo Dupont
Bo Dupont Memorial Sloan Kettering Cancer Center
Robert A. Good
Robert A. Good University of Minnesota
Donald B. Kohn
Donald B. Kohn University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Immunology often explore related healthcare fields to broaden their career opportunities. Many choose to pursue nursing paths, as these programs offer a practical foundation in patient care and biomedical sciences. If you are considering nursing, finding the right program is crucial. Sites like lpn programs easy to get into can help you identify accessible Licensed Practical Nurse programs that provide a stepping stone into more advanced nursing roles.

Advancing beyond LPN, nurse practitioner programs allow for more specialized clinical practice. For those wanting to quickly enter a nurse practitioner role, exploring the easiest np program options may offer a practical path forward without compromising quality education.

Mental health is a critical area within immunology research and healthcare. Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are popular due to their focus on holistic patient care. To ensure a strong clinical experience, prospective students should consult lists of the best pmhnp programs, which highlight those with superior clinical placement rates.

Cost is always a consideration, and many students seek affordable education options. The cheapest pmhnp certificate programs provide valuable pathways to certification without excessive financial burden, making specialized nursing education more accessible to a broader audience.

Best Scientists Citing Richard J. O'Reilly

Trending Scientists